BunyaVax
↗Lelystad, Netherlands
BunyaVax is a Dutch biotechnology company specializing in the development of next-generation vaccines against emerging infectious diseases and cancer. Spun off from Wageningen Bioveterinary Research (WBVR) in 2017, the company utilizes a proprietary 'plug-and-play' RNA particle technology and live-attenuated platforms to rapidly create safe and efficacious vaccines.
The company's technology is specifically designed to address the Bunyavirales order, which includes several high-priority pathogens identified by the WHO. BunyaVax operates on a 'One Health' principle, developing solutions that protect both livestock and human populations from zoonotic threats.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Revenue:$1M-$5M
Founded:2017
Ownership:private
Status:operating
FUNDING
Stage:Series A / Grant-Funded
Total Raised:$38.4M
Investors:CEPI (Coalition for Epidemic Preparedness Innovations), European Union (Horizon 2020), NWO (Netherlands Organisation for Scientific Research), Ministry of Economic Affairs (Netherlands)
PIPELINE
Stage:Phase 1
Lead Drug Stage:Phase 1 (Human)
Modalities:Live-attenuated virus, RNA particle technology, Plug-and-Play platform
Active Trials:1
Trial Phases:Phase 1: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Wageningen Bioveterinary Research (WBVR), CEPI, CR2O (Clinical Research Organization), LARISSA Consortium
COMPETITION
Position:Emerging
Competitors:Themis Bioscience (Merck), Valneva, Bavarian Nordic, CureVac
LEADERSHIP
Key Executives:
Carine Punt - CEO
Jeroen Kortekaas - CSO & Founder
Paul Wichgers Schreur - COO & Founder
Scientific Founders:Jeroen Kortekaas, Paul Wichgers Schreur
Board Members:Prof. Eric Claassen (Advisory Board), René Aerts (Advisory Board), Marianne Boes (Advisory Board), Danny Goovaerts (Advisory Board)
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of BunyaVax and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with BunyaVax. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.